Yüklüyor......
Dexamethasone in hyperleukocytic acute myeloid leukemia
Patients with acute myeloid leukemia and a high white blood cell count are at increased risk of early death and relapse. Because mediators of inflammation contribute to leukostasis and chemoresistance, dexamethasone added to chemotherapy could improve outcomes. This retrospective study evaluated the...
Kaydedildi:
| Yayımlandı: | Haematologica |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Ferrata Storti Foundation
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058767/ https://ncbi.nlm.nih.gov/pubmed/29519869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.184267 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|